LDT Oversight Remains Under CLIA, for Now
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
CMS recently proposed a rule that would make the False Claims Act rule the standard for overpayments under the Affordable Care Act regulations.
Unsurprisingly, the American Hospital Association and other industry groups don’t think that increase is anywhere near adequate.
Starting April 4, Medicare beneficiaries can get eight free tests per month for each month the public health emergency remains in effect.